Neonatal chronic lung disease, oxygen dependency, and a family history of asthma.
We examined the relationship between a family history of asthma (FHA), neonatal chronic lung disease (CLD), and oxygen dependency in an inception cohort study of all 24- to 30-week gestation infants admitted to the sole tertiary perinatal center in Western Australia. One hundred and forty-four infants were admitted during the study period; 116 had data analyzed, 112 of whom survived to discharge. Respiratory morbidity was common and the prevalence increased with decreasing gestation. Hyaline membrane disease (HMD) occurred in 92 (79%) and CLD (oxygen dependency at 28 days) in 62 (53%); 35 (30%) were oxygen dependent at 36 weeks corrected age, and 16 (14%) were oxygen dependent at term. Thirty-two infants had an FHA which was equally distributed between those infants with and without CLD. Infants with an FHA were more likely to be oxygen dependent at term (relative risk 4.4; 95% Cl 1.7,11.1). Thirty-eight percent of mothers smoked; 68% of their infants developed HMD compared to 89% of those whose mothers did not smoke. Logistic regression identified GA<28 weeks (OR 7.3; 95% Cl 1.4,39), severe HMD (OR 4.8; 95% Cl 1.1,22), and FHA (OR 11.0; 95% Cl 2.3,53) as the only factors associated with an increased risk of being oxygen dependent at term. The duration of supplemental oxygen in infants with CLD was significantly related to decreasing gestation, greater degree of barotrauma, presence of HMD, pregnancy-induced hypertension in the mother, duration of patent ductus arteriosus, and an FHA. An FHA may worsen chronic lung disease in the neonate, but is not involved as a causal factor. Clinicians should be aware of its influence on duration of oxygen supplementation when counselling parents of very preterm infants.
Hagan
R
R
Department of Newborn Services, King Edward Memorial Hospital for Women, Perth, Australia.
Minutillo
C
C
French
N
N
Reese
A
A
Landau
L
L
LeSouef
P
P
D001249:Asthma / Q000150:complications* / Q000235:genetics; D001315:Australia; D001997:Bronchopulmonary Dysplasia / Q000150:complications; D002908:Chronic Disease; D015331:Cohort Studies; D005190:Family; D005865:Gestational Age; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D007234:Infant, Premature; D016014:Linear Models; D016015:Logistic Models; D008171:Lung Diseases / Q000209:etiology* / Q000235:genetics / Q000401:mortality* / Q000628:therapy; D010102:Oxygen Inhalation Therapy / Q000009:adverse effects*; D011446:Prospective Studies; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors